amarbellisine

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Abou-Donia, Amina: 1 article (07/2010)
2.	Andolfi, Anna: 1 article (07/2010)
3.	Cimmino, Alessio: 1 article (07/2010)
4.	Dubois, Jacques: 1 article (07/2010)
5.	Evidente, Antonio: 1 article (07/2010)
6.	Gras, Thierry: 1 article (07/2010)
7.	Kiss, Robert: 1 article (07/2010)
8.	Kornienko, Alexander: 1 article (07/2010)
9.	Lallemand, Benjamin: 1 article (07/2010)
10.	Lamoral-Theys, Delphine: 1 article (07/2010)

1.	Neoplasms (Cancer) 07/23/2010 - "Altogether, the data from the present study revealed that lycorine (1), amarbellisine (6), haemanthamine (14), and haemanthidine (15) are potentially useful chemical scaffolds to generate further compounds to combat cancers associated with poor prognoses, especially those naturally resistant to apoptosis, such as glioblastoma, melanoma, non-small-cell lung, and metastatic cancers."
2.	Melanoma (Melanoma, Malignant) 07/23/2010 - "Altogether, the data from the present study revealed that lycorine (1), amarbellisine (6), haemanthamine (14), and haemanthidine (15) are potentially useful chemical scaffolds to generate further compounds to combat cancers associated with poor prognoses, especially those naturally resistant to apoptosis, such as glioblastoma, melanoma, non-small-cell lung, and metastatic cancers."
3.	Glioblastoma (Glioblastoma Multiforme) 07/23/2010 - "Altogether, the data from the present study revealed that lycorine (1), amarbellisine (6), haemanthamine (14), and haemanthidine (15) are potentially useful chemical scaffolds to generate further compounds to combat cancers associated with poor prognoses, especially those naturally resistant to apoptosis, such as glioblastoma, melanoma, non-small-cell lung, and metastatic cancers."